Egle Therapeutics SAS (Egle), a clinical-stage biotechnology company pioneering precision medicines that modulate regulatory ...

But quality-of-life findings should be considered alongside DFS benefit, says researcher ...

Cancer survivors visit the Fight Colorectal Cancer "United in Blue" flag installation on the National Mall to spotlight the ...

SUZHOU, China, Feb. 16, 2026 /PRNewswire/ — CStone Pharmaceuticals ("CStone," HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of therapies for ...

2 月 6 日，CDE 官网显示，康方生物的卡度尼利单抗皮下注射剂型获得临床试验默示许可，适应症为联合奥沙利铂和卡培他滨（XELOX）方案一线治疗不可手术切除的局部晚期或转移性胃腺癌或胃食管结合部腺癌。 卡度尼利单抗是康方生物自主研发的全球首创 PD-1/CTLA ...

1 、靶向PD-1和CTLA-4的双靶点免疫药物皮下注射剂型获批开展临床试验 2026年2月6日，全球首创的靶向PD-1和CTLA-4双抗卡度尼利单抗皮下注射剂型获CDE临床默示许可，拟联合XELOX化疗方案一线治疗不可手术的局部晚期或转移性胃、胃食管结合部腺癌。该皮下剂型将显著 ...

2月11日消息，国家知识产权局信息显示，迈威（上海）生物科技股份有限公司申请一项名为“靶向CCR8和CTLA-4的双特异性重组蛋白及其应用”的专利。申请公布号为CN121494989A，申请号为CN202511103297.9，申请公布日期为2026年2月10日，申请日期为2025年8月7日，发明人郭 ...

This afternoon, we released financial results for the quarter and full year ended December 31, 2025, and recent corporate updates. The press release is available on the Investors section of our ...

Anthropic launched its latest AI model, Claude Opus 4.6, which is better at coding, sustaining tasks for longer and creating higher-quality professional work, the company said. The company's models ...